Literature DB >> 25100723

Genotype-dependent molecular evolution of sheep bovine spongiform encephalopathy (BSE) prions in vitro affects their zoonotic potential.

Zuzana Krejciova1, Marcelo A Barria1, Michael Jones2, James W Ironside1, Martin Jeffrey3, Lorenzo González3, Mark W Head4.   

Abstract

Prion diseases are rare fatal neurological conditions of humans and animals, one of which (variant Creutzfeldt-Jakob disease) is known to be a zoonotic form of the cattle disease bovine spongiform encephalopathy (BSE). What makes one animal prion disease zoonotic and others not is poorly understood, but it appears to involve compatibility between the prion strain and the host prion protein sequence. Concerns have been raised that the United Kingdom sheep flock may have been exposed to BSE early in the cattle BSE epidemic and that serial BSE transmission in sheep might have resulted in adaptation of the agent, which may have come to phenotypically resemble scrapie while maintaining its pathogenicity for humans. We have modeled this scenario in vitro. Extrapolation from our results suggests that if BSE were to infect sheep in the field it may, with time and in some sheep genotypes, become scrapie-like at the molecular level. However, the results also suggest that if BSE in sheep were to come to resemble scrapie it would lose its ability to affect humans.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Molecular Evolution; Prion; Prion Disease; Protein Conformation; Protein Misfolding; Protein Misfolding Cyclic Amplification; Sheep BSE; Zoonosis

Mesh:

Substances:

Year:  2014        PMID: 25100723      PMCID: PMC4176218          DOI: 10.1074/jbc.M114.582965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Prion diseases: BSE in sheep bred for resistance to infection.

Authors:  Fiona Houston; Wilfred Goldmann; Angela Chong; Martin Jeffrey; Lorenzo González; James Foster; David Parnham; Nora Hunter
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

2.  The PrP(C) C1 fragment derived from the ovine A136R154R171PRNP allele is highly abundant in sheep brain and inhibits fibrillisation of full-length PrP(C) protein in vitro.

Authors:  Lauren Campbell; Andrew C Gill; Gillian McGovern; Clara M O Jalland; John Hopkins; Michael A Tranulis; Nora Hunter; Wilfred Goldmann
Journal:  Biochim Biophys Acta       Date:  2013-03-06

3.  Conserved features of intermediates in amyloid assembly determine their benign or toxic states.

Authors:  Rajaraman Krishnan; Jessica L Goodman; Samrat Mukhopadhyay; Chris D Pacheco; Edward A Lemke; Ashok A Deniz; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

4.  Distinct profiles of PrP(d) immunoreactivity in the brain of scrapie- and BSE-infected sheep: implications for differential cell targeting and PrP processing.

Authors:  Lorenzo González; Stuart Martin; Martin Jeffrey
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

5.  Efficient in vitro amplification of chronic wasting disease PrPRES.

Authors:  Timothy D Kurt; Matthew R Perrott; Carol J Wilusz; Jeffrey Wilusz; Surachai Supattapone; Glenn C Telling; Mark D Zabel; Edward A Hoover
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

6.  Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.

Authors:  Joaquín Castilla; Dennisse Gonzalez-Romero; Paula Saá; Rodrigo Morales; Jorge De Castro; Claudio Soto
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

7.  Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies.

Authors:  Jan Priem; Jan P M Langeveld; Lucien J M van Keulen; Fred G van Zijderveld; Olivier Andreoletti; Alex Bossers
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

8.  Monitoring for bovine spongiform encephalopathy in sheep in Great Britain, 1998-2004.

Authors:  Michael Stack; Martin Jeffrey; Simon Gubbins; Steve Grimmer; Lorenzo González; Stuart Martin; Melanie Chaplin; Paul Webb; Marion Simmons; Yvonne Spencer; Peter Bellerby; James Hope; John Wilesmith; Danny Matthews
Journal:  J Gen Virol       Date:  2006-07       Impact factor: 3.891

9.  Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep.

Authors:  Jan P M Langeveld; Jorg G Jacobs; Jo H F Erkens; Alex Bossers; Fred G van Zijderveld; Lucien J M van Keulen
Journal:  BMC Vet Res       Date:  2006-06-09       Impact factor: 2.741

10.  Molecular model of prion transmission to humans.

Authors:  Michael Jones; Darren Wight; Rona Barron; Martin Jeffrey; Jean Manson; Christopher Prowse; James W Ironside; Mark W Head
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

View more
  4 in total

1.  Longitudinal Detection of Prion Shedding in Saliva and Urine by Chronic Wasting Disease-Infected Deer by Real-Time Quaking-Induced Conversion.

Authors:  Davin M Henderson; Nathaniel D Denkers; Clare E Hoover; Nina Garbino; Candace K Mathiason; Edward A Hoover
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

2.  Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner.

Authors:  Zuzana Krejciova; James Alibhai; Chen Zhao; Robert Krencik; Nina M Rzechorzek; Erik M Ullian; Jean Manson; James W Ironside; Mark W Head; Siddharthan Chandran
Journal:  J Exp Med       Date:  2017-11-15       Impact factor: 14.307

3.  Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions.

Authors:  Marcelo A Barria; Adriana Libori; Gordon Mitchell; Mark W Head
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

4.  Generation of human chronic wasting disease in transgenic mice.

Authors:  Zerui Wang; Kefeng Qin; Manuel V Camacho; Ignazio Cali; Jue Yuan; Pingping Shen; Justin Greenlee; Qingzhong Kong; James A Mastrianni; Wen-Quan Zou
Journal:  Acta Neuropathol Commun       Date:  2021-09-26       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.